$BPTH News Article - Bio-Path Holdings Announces C
Post# of 88933
(Total Views: 51)
Posted On: 01/10/2024 10:15:46 AM
$BPTH News Article - Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients https://marketwirenews.com/news-releases/bio-...24997.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼